New cancer clinical trial: Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Published on: January 30, 2019 at 12:00PM
Conditions:   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Prostate Carcinoma Metastatic in the Bone;   Stage IV Prostate Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8
Interventions:   Drug: Abiraterone Acetate;   Drug: Apalutamide;   Drug: Prednisone
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
http://bit.ly/2RXhYqK